Navigation Links
CRH Medical Corp. Joins OTCQX
Date:8/17/2010

NEW YORK, Aug. 17 /PRNewswire-FirstCall/ -- Pink OTC Markets Inc. (OTCQX: PINK), the financial information and technology services company that operates the leading electronic quotation and trading system in the U.S. OTC securities market, today announced that CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM), a Canadian-based medical technology company, is now trading on the OTC market's highest tier, OTCQX®.

(Logo:  http://photos.prnewswire.com/prnh/20090708/NY43125LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090708/NY43125LOGO)

CRH Medical began trading today on the OTC market's prestigious tier, OTCQX International. Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcqx.com and www.otcmarkets.com.

"OTCQX companies demonstrate their commitment to providing superior information to investors and maintaining the highest quality standards," said R. Cromwell Coulson, President and CEO of Pink OTC Markets. "We are pleased to welcome CRH Medical to OTCQX."

Berenbaum Weinshienk PC will serve as CRH Medical's Principal American Liaison ("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements.

About CRH Medical Corp.

CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM) specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology.  CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I – IV.  CRH employs two commercialization strategies: first, CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to its partner physicians ("Partnership Program"). In addition, CRH operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids, fissures, and colon cancer screening.  The Company currently operates eight Centers geographically dispersed through the U.S. The Company's goal is to establish the CRH O'Regan System as the standard for hemorrhoid treatment.

About OTCQX

The OTCQX Marketplace is the premier tier of the U.S. OTC market.  Investor-focused companies use the quality controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated U.S. broker-dealers. The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a U.S. stock exchange.  For more information and to view a full list of OTCQX companies, visit www.otcqx.com.

About Pink OTC Markets Inc.

Pink OTC Markets Inc. (OTCQX: PINK) operates the leading electronic interdealer quotation and trading system for over 9,000 securities not listed on a U.S. stock exchange. Pink OTC Markets segments these securities into three tiers: the quality-controlled OTCQX marketplace, the U.S. registered and reporting OTCQB marketplace, and the speculative trading Pink Sheets marketplace. These three tiers constitute the third largest U.S. liquidity pool for trading public company shares, after The NASDAQ Stock Market, Inc. and The New York Stock Exchange. Our products and services promote market transparency, improve price discovery, facilitate regulatory compliance, and increase the quality of issuer disclosure, to the benefit of all OTC market participants.  To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit our websites at www.otcmarkets.com, www.pinkotc.com and www.otcqx.com or contact us at info@pinkotc.com.

Subscribe to the OTCQX RSS Feed


'/>"/>
SOURCE Pink OTC Markets Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
2. ISMPP and MPIP Announce New Medical Publishing Website
3. Applications for the September ISMPP Certified Medical Publication Professional Exam Now Being Accepted
4. ISMPP Reiterates Progress in Medical Publications in Response to Senator Grassleys Report
5. New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices
6. NeoStem to Receive $700,000 from the U.S. Armys Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds
7. Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010
8. Dehaier Medical Systems Signs $1.6 Million Oxygen-Chip Sales Contract
9. Medical Simulation Corporation Partners with Hutchinson Technology in Training of Healthcare Professionals on Noninvasive Tissue Oxygenation Monitoring
10. Cardon Children's Medical Center Adopts TrueVision 3D Surgical Visualization Platform for Department of Pediatric Neurosurgery
11. Stemedica Announces the Appointment of Dr. Csar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)... -- NetworkNewsWire Editorial Coverage  ... Cancer remains one of the ... care systems, in terms of costs and resources. However, as ... development of innovative and efficient therapies that demonstrate higher chances ... of cancer treatments, a growing number of patients receiving immuno-oncology ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
Breaking Biology Technology:
(Date:3/2/2017)... Who risk to be deprived of its imprint in ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT EACH ... using capacitive technology represent a fast growing market, especially ... increase of 360% of the number of fingerprint sensor ... market between 2014 and 2017 (source : N+1 Singer, ...
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
(Date:2/28/2017)... February 28, 2017 News solutions for biometrics, ... ... from 14 to 16 March, Materna will present its ... how seamless travel is a real benefit for passengers. To ... to their passenger touch point solutions to take passengers through the ...
Breaking Biology News(10 mins):